Goat Anti-ANAPC11 Antibody
| Applications | WB |
| Reactivities | Human |
Products
Human IgG (Fc specific) goat polyclonal antibody, Aff - Purified
| Applications | ELISA: 1-5 µg/ml. Immunohistochemistry on Frozen Sections. |
| Reactivities | Human |
| Conjugation | Unconjugated |
Human IgE (Fc specific) goat polyclonal antibody, TRITC
| Applications | Can be used for direct Immunofluorescence staining of cytoplasmic IgE of appropriately treated cell and tissue substrates; to demonstrate immunoglobulins or specific antibodies in cells and tissues; to identify circulating antibodies in serodiagnostic microbiology and autoimmune diseases. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Recommended working dilutions: 1/10 - 1/30. |
| Reactivities | Human |
| Conjugation | TRITC |
Human IgE (Fc specific) goat polyclonal antibody, Azide Free
| Applications | Can be used as unlabelled secondary antibody for Indirect detection of IgE in Human cell, tissue substrates and body fluids in immunofluorescence and immunoenzyme assay methods; for the production of immunoconjugates with a selected marker; to prepare insoluble immunoaffinity adsorbents by coupling to an artificial carrier; as catching or detecting antibody reagent in non-isotopic assay methodology (e.g. ELISA) to identify and measure IgE in human serum or other body fluid. When applied in any immunocytochemical or histochemical staining procedure or solid phase coupling technique, the optimum concentration of the IgG preparation should be established. Recommended Working Dilutions: Histochemical and Cytochemical Use: 1/100-1/250. ELISA and comparable non-precipitating antibody-binding assays: 1/500-1/5,000. Performance testing: Isotype specificity and quantitative specific recognition ability are further evaluated at the high level of sensitivity by direct singe and simultaneous double staining of different types of human cells, using counterstaining with reference conjugates with a different marker. The immunoconjugate is further tested in ELISA-type assays. |
| Reactivities | Human |
| Conjugation | Unconjugated |
Human IgA (Secretory component) goat polyclonal antibody, FITC
| Applications | Can be used as reagent for the direct detection of secretory component in human cells, tissues and body fluids in Immunofluorescence, as detection reagent in non-isotopic methodology and solid phase immunochemistry (e.g. ELISA). This immunoconjugate is not pre-diluted and the optimum working dilution should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working Dilutions: 1/20-1/80. |
| Reactivities | Human |
| Conjugation | FITC |
Human IgD (Fc specific) goat polyclonal antibody, TRITC
| Applications | Can be used in direct Immunofluorescence staining of cytoplasmic IgD of appropriately treated cell and tissue substrates; to demonstrate immunoglobulins or specific antibodies in cells and tissues; to identify circulating antibodies in serodiagnostic microbiology and autoimmune diseases. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Working dilutions: 1/10 - 1/30. |
| Reactivities | Human |
| Conjugation | TRITC |
Human IgD (Fc specific) goat polyclonal antibody, FITC
| Applications | Can be used in Immunocytochemical and Immunohistochemical staining for the detection of IgD at the cellular and subcellular level by staining of appropriately treated cell and tissue substrates; to identify and measure IgD in human serum or other body fluids. This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. Recommended working dilutions: 1/10 - 1/40, depending on the method used. |
| Reactivities | Human |
| Conjugation | FITC |
Complement C5 (C5) goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Human |
Human Kappa Light Chain (free and bound) goat polyclonal antibody, Azide Free
| Applications | ELISA, ID, IF, IP, WB |
| Reactivities | Human |
Complement C3 (C3) goat polyclonal antibody, HRP
| Applications | ELISA, ID, IF, IHC, WB |
| Reactivities | Human |
Human Lambda Light Chain (free and bound) goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Human |
Human Kappa Light Chain (free and bound) goat polyclonal antibody, TRITC
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Human |
Properdin (CFP) goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Human |
Lactoferrin (LTF) goat polyclonal antibody, FITC
| Applications | ELISA, ID, IF, IHC, IP |
| Reactivities | Human |
活动过滤器
优化搜索结果
Target Symbol
- ALDOA (7)
- AIRE (5)
- CALNEXIN (5)
- ERP57 (5)
- GAPDH (5)
- LACTOFERRIN (5)
- RAB27A (5)
- ALB (4)
- ALPHA 1 ANTITRYPSIN (4)
- ATAXIN 3 (4)
- CA1 (4)
- CHM (4)
- COMPLEMENT C3 (4)
- FIBRINOGEN ALPHA CHAIN (4)
- MSTN (4)
- PTHLH (4)
- TNNI3 (4)
- ADAM12 (3)
- ALDH5A1 (3)
- ALPHA 2 MACROGLOBULIN (3)
- ALPHA TUBULIN (3)
- APOBEC3G (3)
- ARYL HYDROCARBON RECEPTOR (3)
- CD19 (3)
- E CADHERIN (3)
- EEA1 (3)
- FGA (3)
- GFAP (3)
- GJA1 (3)
- GRIA4 (3)
- HRH1 (3)
- LDHA (3)
- PBR (3)
- PCNA (3)
- PCSK9 (3)
- PIM2 (3)
- PTCH1 (3)
- PTH (3)
- RAB11A (3)
- RAB5 (3)
- RETN (3)
- TATA BINDING PROTEIN (3)
- TGFBI (3)
- TXNDC5 (3)
- 5HT3A RECEPTOR (2)
- ACADVL (2)
- ACAT1 (2)
- AIM2 (2)
- ALDH6A1 (2)
- ALDOLASE (2)
- AMACR (2)
- AMHR2 (2)
- AMPK ALPHA 2 (2)
- ANNEXIN A1 (2)
- AOC3 (2)
- AP3D1 (2)
- APOA1 (2)
- APOL6 (2)
- APOLIPOPROTEIN D (2)
- APOLIPOPROTEIN H (2)
- APOLIPOPROTEIN L 1 (2)
- ARGINASE 1 (2)
- AROMATASE (2)
- ARSB (2)
- BAG3 (2)
- BDNF (2)
- BLVRB (2)
- BMI1 (2)
- BPIFA1 (2)
- C14ORF68 (2)
- CANNABINOID RECEPTOR I (2)
- CAPN1 (2)
- CATALASE (2)
- CATHEPSIN D (2)
- CCL11 (2)
- CCL15 (2)
- CD13 (2)
- CD14 (2)
- CD4 (2)
- CD45 (2)
- CD63 (2)
- CIRBP (2)
- CLCA1 (2)
- CLU (2)
- CMA1 (2)
- CMG1 (2)
- COMT (2)
- CONTACTIN 1 (2)
- CPT1A (2)
- CPT2 (2)
- CREATINE KINASE M TYPE (2)
- CRHR1 (2)
- CRTC2 (2)
- CSK (2)
- CST8 (2)
- CYTOCHROME P450 26B (2)
- CYTOKERATIN 19 (2)
- DCTN1 (2)
- DGAT1 (2)
- DHLAG (2)
Applications
Conjugates
Isotypes
Clonalities
Assay Types
Families
- Druggable Genome (764)
- Transmembrane (297)
- Secreted Protein (141)
- Transcription Factors (129)
- ES Cell Differentiation/IPS (78)
- Protease (43)
- Protein Kinase (39)
- Stem cell - Pluripotency (39)
- GPCR (37)
- Adult stem cells (15)
- Embryonic stem cells (14)
- Phosphatase (14)
- Ion Channels: Other (12)
- Induced pluripotent stem cells (10)
- Ion Channels: Cys-loop Receptors (10)
- Nuclear Hormone Receptor (10)
- P450 (8)
- Cancer stem cells (6)
- Ion Channels: Potassium (5)
- Stem cell relevant signaling - JAK/STAT signaling pathway (5)
- Ion Channels: Transient receptor potential (4)
- Stem cell relevant signaling - DSL/Notch pathway (4)
- Ion Channels: Glutamate Receptors (3)
- Ion Channels: ATP Receptors (1)
- Ion Channels: Calcium (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
Pathways
- Metabolic pathways (110)
- Pathways in cancer (53)
- Neuroactive ligand-receptor interaction (44)
- Huntington's disease (40)
- MAPK signaling pathway (40)
- Complement and coagulation cascades (33)
- Calcium signaling pathway (31)
- Cytokine-cytokine receptor interaction (30)
- Endocytosis (30)
- Regulation of actin cytoskeleton (29)
- Alzheimer's disease (27)
- Focal adhesion (27)
- Natural killer cell mediated cytotoxicity (24)
- T cell receptor signaling pathway (23)
- Cell adhesion molecules (CAMs) (22)
- Neurotrophin signaling pathway (22)
- Prostate cancer (21)
- Chemokine signaling pathway (20)
- Hematopoietic cell lineage (20)
- Wnt signaling pathway (20)
- Jak-STAT signaling pathway (19)
- Antigen processing and presentation (18)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (18)
- Gap junction (18)
- Melanogenesis (18)
- Melanoma (18)
- PPAR signaling pathway (18)
- Toll-like receptor signaling pathway (18)
- Adherens junction (17)
- Glycolysis / Gluconeogenesis (17)
- Parkinson's disease (17)
- Adipocytokine signaling pathway (16)
- Bladder cancer (16)
- Dilated cardiomyopathy (16)
- Endometrial cancer (16)
- Hypertrophic cardiomyopathy (HCM) (16)
- Insulin signaling pathway (16)
- Ubiquitin mediated proteolysis (16)
- Amyotrophic lateral sclerosis (ALS) (15)
- Apoptosis (15)
- Chronic myeloid leukemia (15)
- Leukocyte transendothelial migration (15)
- B cell receptor signaling pathway (14)
- Fc epsilon RI signaling pathway (14)
- Fc gamma R-mediated phagocytosis (14)
- Glioma (14)
- GnRH signaling pathway (14)
- Lysosome (14)
- Non-small cell lung cancer (14)
- Renal cell carcinoma (14)
- Systemic lupus erythematosus (14)
- p53 signaling pathway (14)
- Acute myeloid leukemia (13)
- Arachidonic acid metabolism (13)
- Arginine and proline metabolism (13)
- Cell cycle (13)
- Pathogenic Escherichia coli infection (13)
- Pyruvate metabolism (13)
- Vascular smooth muscle contraction (13)
- Viral myocarditis (13)
- Citrate cycle (TCA cycle) (12)
- Colorectal cancer (12)
- ErbB signaling pathway (12)
- Fatty acid metabolism (12)
- Long-term depression (12)
- Pancreatic cancer (12)
- Primary immunodeficiency (12)
- Thyroid cancer (12)
- Tight junction (12)
- Type I diabetes mellitus (12)
- Axon guidance (11)
- Basal cell carcinoma (11)
- Butanoate metabolism (11)
- Oxidative phosphorylation (11)
- RIG-I-like receptor signaling pathway (11)
- Tryptophan metabolism (11)
- Long-term potentiation (10)
- NOD-like receptor signaling pathway (10)
- Propanoate metabolism (10)
- TGF-beta signaling pathway (10)
- VEGF signaling pathway (10)
- Alanine (9)
- Glutathione metabolism (9)
- Small cell lung cancer (9)
- aspartate and glutamate metabolism (9)
- mTOR signaling pathway (9)
- ABC transporters (8)
- Allograft rejection (8)
- Androgen and estrogen metabolism (8)
- Base excision repair (8)
- Cardiac muscle contraction (8)
- Cytosolic DNA-sensing pathway (8)
- ECM-receptor interaction (8)
- Epithelial cell signaling in Helicobacter pylori infection (8)
- Phenylalanine metabolism (8)
- Prion diseases (8)
- Retinol metabolism (8)
- Tyrosine metabolism (8)
- Metabolism of xenobiotics by cytochrome P450 (7)
- Nucleotide excision repair (7)
- Oocyte meiosis (7)
- Type II diabetes mellitus (7)
- Vibrio cholerae infection (7)
- Drug metabolism - cytochrome P450 (6)
- Hedgehog signaling pathway (6)
- Histidine metabolism (6)
- Maturity onset diabetes of the young (6)
- Progesterone-mediated oocyte maturation (6)
- Valine (6)
- beta-Alanine metabolism (6)
- leucine and isoleucine degradation (6)
- Autoimmune thyroid disease (5)
- Cysteine and methionine metabolism (5)
- Glycerolipid metabolism (5)
- Graft-versus-host disease (5)
- Linoleic acid metabolism (5)
- Lysine degradation (5)
- Methane metabolism (5)
- Purine metabolism (5)
- Regulation of autophagy (5)
- Renin-angiotensin system (5)
- Spliceosome (5)
- Taste transduction (5)
- Asthma (4)
- Basal transcription factors (4)
- Ether lipid metabolism (4)
- Fructose and mannose metabolism (4)
- Glycine (4)
- Glyoxylate and dicarboxylate metabolism (4)
- Mismatch repair (4)
- Primary bile acid biosynthesis (4)
- Ribosome (4)
- serine and threonine metabolism (4)
- DNA replication (3)
- Dorso-ventral axis formation (3)
- Drug metabolism - other enzymes (3)
- Glycerophospholipid metabolism (3)
- Glycosaminoglycan degradation (3)
- Limonene and pinene degradation (3)
- Nicotinate and nicotinamide metabolism (3)
- Nitrogen metabolism (3)
- Non-homologous end-joining (3)
- Olfactory transduction (3)
- Porphyrin and chlorophyll metabolism (3)
- Proteasome (3)
- RNA degradation (3)
- SNARE interactions in vesicular transport (3)
- Taurine and hypotaurine metabolism (3)
- Amino sugar and nucleotide sugar metabolism (2)
- Ascorbate and aldarate metabolism (2)
- C21-Steroid hormone metabolism (2)
- Homologous recombination (2)
- Inositol phosphate metabolism (2)
- N-Glycan biosynthesis (2)
- Notch signaling pathway (2)
- One carbon pool by folate (2)
- Pentose phosphate pathway (2)
- Phenylalanine (2)
- Phosphatidylinositol signaling system (2)
- Riboflavin metabolism (2)
- Synthesis and degradation of ketone bodies (2)
- Terpenoid backbone biosynthesis (2)
- alpha-Linolenic acid metabolism (2)
- tyrosine and tryptophan biosynthesis (2)
- Aminoacyl-tRNA biosynthesis (1)
- Biosynthesis of unsaturated fatty acids (1)
- Caffeine metabolism (1)
- D-Glutamine and D-glutamate metabolism (1)
- Fatty acid biosynthesis (1)
- Lysine biosynthesis (1)
- O-Glycan biosynthesis (1)
- Pantothenate and CoA biosynthesis (1)
- Pentose and glucuronate interconversions (1)
- Pyrimidine metabolism (1)
- Starch and sucrose metabolism (1)
- Vitamin B6 metabolism (1)
